Dr. Bin Lian is a senior expert in melanoma and genitourinary cancers in China. He has long been dedicated to the clinical management and translational research of melanoma, renal cell carcinoma, urothelial carcinoma, prostate cancer, and sarcomas. As a senior visiting scholar at the Moffitt Cancer Center in the United States, he gained strong international academic exposure and extensive clinical research experience.
Dr. Lian has substantial expertise in chemotherapy, targeted therapy, immunotherapy, and comprehensive treatment strategies for melanoma, genitourinary cancers, and sarcomas. He is particularly experienced in managing mucosal melanoma arising in the nasopharynx, oropharynx, anorectum, genitourinary tract, and esophagus.
He has led and participated in numerous national research projects and has been deeply involved in registration clinical trials for both international and domestic innovative anticancer drugs. His research findings have been cited by authoritative guidelines such as the NCCN. Dr. Lian has also contributed to drafting and updating multiple national oncology guidelines, playing an important role in advancing standardized care for melanoma and genitourinary malignancies in China.
